Craniomaxillofacial implants is revolutionizing the healthcare industry by providing improved treatment options for facial and cranial injuries or any craniomaxillofacial abnormalities. 3D printing technology is also enabling manufacturers to provide customized implants according to the requirement of patients, which makes the market more attractive. Road accidents are considered to be the common reason for most of the craniomaxillofacial injuries. Increased incidence of facial fractures is expected to propel the global craniomaxillofacial market. According to a study examining the epidemiology of boxing injuries in the U.S., in 2013, head and neck injuries accounted for 22.5%, leading to increase in craniomaxillofacial surgeries. In 2012, a study conducted by the Michigan State University revealed that the rate of craniomaxillofacial injuries in people not wearing helmets was 37.2%. According to the Association for Safe International Road Travel in the U.S., almost 2.35 million people are injured each year in road accidents, which, in turn, support the craniomaxillofacial implants market.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/773

Market Dynamics
Craniomaxillofacial implants offer benefits such as customization based on the requirement of patient with the help of newly advanced 3D printing technology. Furthermore, growing prevalence of facial injuries is also expected to favor the growth of craniomaxillofacial implants. Emerging techniques for facial and cranial surgical procedures with higher success rate will also promote the use of craniomaxillofacial implants throughout the forecast period. Introduction of robotic arm assisted craniomaxillofacial surgery makes the surgery safer and efficient. Advancements in bioabsorable implants for cranial fixation are expected to drive the craniomaxillofacial implants market. Modern approaches such as image-based 3D modeling using computer-assisted design (CAD) and computer-assisted manufacturing (CAM) of implants to create surgical templates that are more precise than the other craniomaxillofacial implants, which is expected to increase the market for craniomaxillofacial implants.

Market Taxonomy
This report segments the global craniomaxillofacial implants for the medical sector market, on the basis of product, raw material, application, property, and region. On the basis of product, the global craniomaxillofacial implants market is classified into bone graft substitutes, distraction systems, total TMJ replacement systems, cranial flap fixation systems, thoracic fixation systems, dural repair products and screw, plates, and contourable mesh. Raw materials for craniomaxillofacial implants include metals, ceramics, polymers, and biomaterials. The internal fixators and external fixators are segmented under application segment. On the basis of property, the global craniomaxillofacial implants market is classified into resorbable fixators and non-resorbable fixators.

Key features of the study:
This report provides an in-depth analysis of global craniomaxillofacial implants in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global craniomaxillofacial implants for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.

Patient specific implants, 3D implants, growing demand for bioresorbable materials, and growing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Whereas, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures, combined with refinements in surgical equipment such as resorbable plating and distractors, have improved surgical outcomes, while minimizing morbidity. The development of bone graft substitutes with the help of gene thera py and nanotechnology is also expected to drive the craniomaxillofacial implants market.

Some major players operating in the craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgicssal USA.

Click To Read More On Craniomaxillofacial Implants Market

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.